Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Elotuzumab plus lenalidomide and dexamethasone for newly diagnosed multiple myeloma: a randomized, open-label, phase 2 study in Japan.
Kubo K, Hori M, Ohta K, Handa H, Hatake K, Matsumoto M, Hagiwara S, Ohashi K, Nakaseko C, Suzuki K, Ito S, Kinoshita G, Shelat SG, Miyoshi M, Takezako N. Kubo K, et al. Among authors: miyoshi m. Int J Hematol. 2020 Jan;111(1):65-74. doi: 10.1007/s12185-019-02757-0. Epub 2019 Nov 7. Int J Hematol. 2020. PMID: 31701481 Clinical Trial.
Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.
Nakamae H, Fujisawa S, Ogura M, Uchida T, Onishi Y, Taniwaki M, Utsunomiya A, Matsue K, Takamatsu Y, Usuki K, Tanimoto M, Ishida Y, Ohashi K, Li L, Miyoshi M. Nakamae H, et al. Among authors: miyoshi m. Int J Hematol. 2017 Jun;105(6):792-804. doi: 10.1007/s12185-017-2208-2. Epub 2017 Mar 24. Int J Hematol. 2017. PMID: 28341918 Clinical Trial.
Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy.
Suzuki A, Kakugawa S, Miyoshi M, Hori M, Suzuki K, Furukawa Y, Ohta K. Suzuki A, et al. Among authors: miyoshi m. Leukemia. 2020 Nov;34(11):3088-3090. doi: 10.1038/s41375-020-0860-7. Epub 2020 May 12. Leukemia. 2020. PMID: 32398792 No abstract available.
Risk factors of late arrhythmia recurrences over 12 months after catheter ablation of atrial fibrillation: Insight into atrial cardiomyopathy.
Matsunaga-Lee Y, Inoue K, Tanaka N, Masuda M, Watanabe T, Minamiguchi H, Egami Y, Oka T, Miyoshi M, Okada M, Matsuda Y, Kawasaki M, Kawanami S, Ukita K, Kawamura A, Yasumoto K, Okamoto N, Yano M, Nishino M, Hikoso S, Sunaga A, Dohi T, Okada K, Nakatani D, Sotomi Y, Sakata Y; Osaka Cardiovascular Conference (OCVC)-Arrhythmia Investigators. Matsunaga-Lee Y, et al. Among authors: miyoshi m. Heart Rhythm. 2024 Dec 17:S1547-5271(24)03691-9. doi: 10.1016/j.hrthm.2024.12.018. Online ahead of print. Heart Rhythm. 2024. PMID: 39701441 No abstract available.
Space scan statistics to identify clusters of neonatal mortality associated with bacterial sepsis.
Costa-Nobre DT, Marinonio ASS, Miyoshi MH, Sanudo A, Areco KCN, Kawakami MD, Balda RCX, Konstantyner T, Vieira E Oliveira CN, Bandiera-Paiva P, de Freitas RMV, Teixeira MP, Waldvogel B, de Almeida MF, Guinsburg R, Kiffer CRV. Costa-Nobre DT, et al. Among authors: miyoshi mh. Epidemiol Infect. 2024 Dec 13;152:e169. doi: 10.1017/S0950268824001663. Epidemiol Infect. 2024. PMID: 39668720
Yield of Genetic Testing for Long-QT Syndrome in Elderly Patients With Torsades de Pointes.
Tomidokoro D, Nakamura T, Oka S, Miyazaki Y, Wakamiya A, Ueda N, Nakajima K, Kamakura T, Wada M, Ishibashi K, Inoue Y, Miyamoto K, Nagase S, Kitada S, Sakaue Y, Shiraishi H, Kabutoya T, Takami K, Miyoshi M, Takahashi N, Soeki T, Hiroi Y, Asano Y, Ohno S, Kusano K, Aiba T. Tomidokoro D, et al. Among authors: miyoshi m. Circ Genom Precis Med. 2024 Dec;17(6):e004671. doi: 10.1161/CIRCGEN.124.004671. Epub 2024 Oct 29. Circ Genom Precis Med. 2024. PMID: 39469765 No abstract available.
651 results